Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Cancer metastasis chemoprevention prevents circulating tumour cells from germination

    The war against cancer traces back to the signature event half-a-century ago when the US National Cancer Act was signed into law. The cancer crusade costs trillions with disappointing returns, teasing the poss...

    **aodong **e, Yumei Li, Shu Lian, Yusheng Lu in Signal Transduction and Targeted Therapy (2022)

  2. Article

    Open Access

    Correction to: Embedding similarities between embryos and circulating tumor cells: fundamentals of abortifacients used for cancer metastasis chemoprevention

    An amendment to this paper has been published and can be accessed via the original article.

    Jie Wang, **aobo Yu, Huayi Peng, Yusheng Lu in Journal of Experimental & Clinical Cancer … (2021)

  3. Article

    Open Access

    NOL7 facilitates melanoma progression and metastasis

    Yumei Li, Chunlian Zhong, Jie Wang, Fan Chen in Signal Transduction and Targeted Therapy (2021)

  4. Article

    Open Access

    Embedding similarities between embryos and circulating tumor cells: fundamentals of abortifacients used for cancer metastasis chemoprevention

    The global epidemiological studies reported lower cancer risk after long-term use of contraceptives. Our systematic studies demonstrated that abortifacients are effective in preventing cancer metastases induce...

    Jie Wang, **aobo Yu, Huayi Peng, Yusheng Lu in Journal of Experimental & Clinical Cancer … (2021)

  5. Article

    Open Access

    Author Correction: Achyranthes bidentata polysaccharide can safely prevent NSCLC metastasis via targeting EGFR and EMT

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Chunlian Zhong, **gyi Yang, Yusheng Lu in Signal Transduction and Targeted Therapy (2020)

  6. Article

    Open Access

    Achyranthes bidentata polysaccharide can safely prevent NSCLC metastasis via targeting EGFR and EMT

    Chunlian Zhong, **gyi Yang, Yusheng Lu in Signal Transduction and Targeted Therapy (2020)

  7. No Access

    Article

    WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5–MDM2–p53 pathway

    The key molecules and underlying mechanisms of melanoma metastasis remain poorly understood. Using isobaric tag for relative and absolute quantitation (iTRAQ) proteomic screening, probing of patients’ samples,...

    Yumei Li, Yu Zhou, Bifei Li, Fan Chen, Weiyu Shen, Yusheng Lu, Chunlian Zhong in Oncogene (2020)

  8. Article

    Open Access

    Publisher Correction: Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    **aodong **e, Huifang Nie, Yu Zhou, Shu Lian, Hao Mei, Yusheng Lu in Nature Communications (2020)

  9. Article

    Open Access

    Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles

    There are disease-causing biohazards in the blood that cannot be treated with modern medicines. Here we show that an intelligently designed safe biomaterial can precisely identify, tow and dump a targeted bioh...

    **aodong **e, Huifang Nie, Yu Zhou, Shu Lian, Hao Mei, Yusheng Lu in Nature Communications (2019)

  10. Article

    Open Access

    Redox/NIR dual-responsive MoS2 for synergetic chemo-photothermal therapy of cancer

    The construction of a multifunctional drug delivery system with a variety of advantageous features, including targeted delivery, controlled release and combined therapy, is highly attractive but remains a chal...

    Jian Liu, Feiyang Li, Junxia Zheng, Bifei Li, Doudou Zhang in Journal of Nanobiotechnology (2019)

  11. Article

    Open Access

    Functionalized MoS2-erlotinib produces hyperthermia under NIR

    Molybdenum disulfide (MoS2) has been widely explored for biomedical applications due to its brilliant photothermal conversion ability. In this paper, we report a novel multifunctional MoS2-based drug delivery sys...

    Chen Zhang, Doudou Zhang, Jian Liu, Jie Wang, Yusheng Lu in Journal of Nanobiotechnology (2019)

  12. Article

    Open Access

    Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib

    Sorafenib is approved as a standard therapy for advanced hepatocellular carcinoma (HCC), but its clinical application is limited due to moderate therapeutic efficacy and high incidence of acquired resistance r...

    Ning Zheng, Weiqun Liu, Bifei Li in Journal of Experimental & Clinical Cancer … (2019)

  13. Article

    Open Access

    Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells

    Carcinoma metastasis is triggered by a subpopulation of circulating tumor cells (CTCs). And single immune checkpoint therapy is not good enough to inhibit CTC-induced metastasis. Here, we demonstrate that simu...

    Shu Lian, Ruizhi **e, Yuying Ye, Yusheng Lu, Yunlong Cheng in Scientific Reports (2019)

  14. Article

    Open Access

    Sex-related pharmacokinetic differences and mechanisms of metapristone (RU486 metabolite)

    Metapristone is the primary metabolite of the abortifacient mifepristone (RU486), and is being developed as a safe and effective cancer metastatic chemopreventive agent for both sexes. Here, we systematically ...

    Wenge Chen, Yingying **ao, Jianzhong Chen, Jian Liu, **gwei Shao in Scientific Reports (2017)

  15. No Access

    Article

    A Flavonoid Glycoside Compound from Murraya paniculata (L.) Interrupts Metastatic Characteristics of A549 Cells by Regulating STAT3/NF-κB/COX-2 and EGFR Signaling Pathways

    Metastasis remains the leading cause of death from lung carcinoma. It is urgent to find safe and efficient pre-metastasis preventive agents for cancer survivors. We isolated a flavonoid glycoside, hexamethoxy ...

    Qing Shi, Zhou Jiang, **gyi Yang, Yunlong Cheng, Yaqiong Pang in The AAPS Journal (2017)

  16. Article

    Open Access

    Global deregulation of ginseng products may be a safety hazard to warfarin takers: solid evidence of ginseng-warfarin interaction

    Recent global deregulation of ginseng as the table food raises our concern about the possible ginseng-warfarin interaction that could be life-threatening to patients who take warfarin for preventing fatal stro...

    Haiyan Dong, Ji Ma, Tao Li, Yingying **ao, Ning Zheng, Jian Liu in Scientific Reports (2017)

  17. Article

    Open Access

    The traditional Chinese medicine Achyranthes bidentata and our de novo conception of its metastatic chemoprevention: from phytochemistry to pharmacology

    Our recent biosystems analysis revealed similarities between embryonic implantation and cancer cell adhesion, which suggests that abortifacients may be good for safe and effective metastatic chemoprevention ta...

    Zhou Jiang, Jun Qian, Haiyan Dong, **gyi Yang, **aobo Yu in Scientific Reports (2017)

  18. No Access

    Article

    Aptamer-Conjugated Chitosan-Anchored Liposomal Complexes for Targeted Delivery of Erlotinib to EGFR-Mutated Lung Cancer Cells

    Lung cancer is the leading cancer and has the highest death rate. The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) erlotinib has had a promising response in lung cancer therapy. Unfo...

    Fengqiao Li, Hao Mei, **aodong **e, Huijuan Zhang, Jian Liu in The AAPS Journal (2017)

  19. Article

    Open Access

    Warfarin and coumarin-like Murraya paniculata extract down-regulate EpCAM-mediated cell adhesion: individual components versus mixture for studying botanical metastatic chemopreventives

    We recently defined cancer metastatic chemoprevention as utilizing safe and effective molecules to comprehensively prevent the spark of activation-adhesion-extravasation-proliferation metastatic cascade caused...

    **gwei Shao, Suxia Zhou, Zhou Jiang, Ting Chi, Ji Ma, Minliang Kuo in Scientific Reports (2016)

  20. Article

    Open Access

    Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention

    Metapristone is the most predominant biological active metabolite of mifepristone and being developed as a novel cancer metastasis chemopreventive agent by us. Despite its prominent metastasis chemopreventive ...

    Suhong Yu, Cuicui Yan, **ngtian Yang, Sudang He, Jian Liu in Scientific Reports (2016)

previous disabled Page of 2